0
0

Zero Tolerance for Deceptive Fentanyl Trafficking Act

2/9/2022, 2:44 AM

Congressional Summary of S 3342

Zero Tolerance for Deceptive Fentanyl Trafficking Act

This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Additionally, the bill establishes a new criminal offense and penalties with respect to the deceptive sale of fentanyl, fentanyl analogues, or fentanyl-related substances.

Current Status of Bill S 3342

Bill S 3342 is currently in the status of Bill Introduced since February 27, 2020. Bill S 3342 was introduced during Congress 116 and was introduced to the Senate on February 27, 2020.  Bill S 3342's most recent activity was Read twice and referred to the Committee on the Judiciary. as of February 27, 2020

Bipartisan Support of Bill S 3342

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
2
Democrat Cosponsors
0
Republican Cosponsors
2
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 3342

Primary Policy Focus

Crime and Law Enforcement

Potential Impact Areas

- Border security and unlawful immigration
- Criminal procedure and sentencing
- Drug safety, medical device, and laboratory regulation
- Drug trafficking and controlled substances
- Marketing and advertising

Alternate Title(s) of Bill S 3342

Zero Tolerance for Deceptive Fentanyl Trafficking Act
Zero Tolerance for Deceptive Fentanyl Trafficking Act
A bill to amend the Controlled Substances Act to prohibit the deceptive sale of fentanyl, and for other purposes.

Comments